Personal tools

Coexpression cluster:C4799: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
 
(4 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Coexpression_clusters
{
|full_id=C4799_Mast_acute_Monocytederived_xeroderma_plasma_b_migratory
 

Latest revision as of 14:20, 17 September 2013


Full id: C4799_Mast_acute_Monocytederived_xeroderma_plasma_b_migratory



Phase1 CAGE Peaks

Hg19::chr9:127054217..127054252,+p7@NEK6
Hg19::chr9:127054254..127054276,+p5@NEK6
Hg19::chr9:127054288..127054311,+p8@NEK6


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen
myeloid cell2.28e-51108
common myeloid progenitor2.28e-51108
granulocyte monocyte progenitor cell1.58e-4267
hematopoietic cell1.84e-42177
hematopoietic stem cell5.05e-41168
angioblastic mesenchymal cell5.05e-41168
myeloid lineage restricted progenitor cell3.85e-3966
hematopoietic oligopotent progenitor cell5.50e-39161
hematopoietic multipotent progenitor cell5.50e-39161
myeloid leukocyte4.40e-3672
macrophage dendritic cell progenitor2.76e-3561
monopoietic cell3.57e-3359
monocyte3.57e-3359
monoblast3.57e-3359
promonocyte3.57e-3359
leukocyte3.75e-29136
hematopoietic lineage restricted progenitor cell2.74e-26120
defensive cell2.97e-2548
phagocyte2.97e-2548
nongranular leukocyte1.38e-20115
classical monocyte5.41e-1942
CD14-positive, CD16-negative classical monocyte5.41e-1942
dendritic cell1.82e-1310
conventional dendritic cell3.05e-118
stuff accumulating cell3.75e-1187
macrophage1.04e-086
immature conventional dendritic cell1.93e-085
common dendritic progenitor1.93e-085
mesenchymal cell2.19e-08354
histamine secreting cell3.13e-085
biogenic amine secreting cell3.13e-085
granulocytopoietic cell3.13e-085
mast cell3.13e-085
mast cell progenitor3.13e-085
basophil mast progenitor cell3.13e-085
connective tissue cell4.16e-08361
motile cell7.04e-07386
Uber Anatomy
Ontology termp-valuen
bone marrow7.31e-3776
hematopoietic system1.82e-3498
blood island1.82e-3498
bone element3.12e-3482
immune system7.07e-3493
hemolymphoid system1.93e-30108
skeletal element1.88e-2990
skeletal system8.45e-27100
musculoskeletal system3.22e-12167
lateral plate mesoderm1.30e-09203
connective tissue1.16e-07371
neural tube9.29e-0756
neural rod9.29e-0756
future spinal cord9.29e-0756
neural keel9.29e-0756
Disease
Ontology termp-valuen
myeloid leukemia4.93e-1231
leukemia2.06e-1039
hematologic cancer3.74e-0951
immune system cancer3.74e-0951


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)
MA0003.10.0471418
MA0004.10.826076
MA0006.10.639288
MA0007.10.804807
MA0009.11.3275
MA0014.10.118426
MA0017.11.64148
MA0019.10.990656
MA0024.12.72668
MA0025.11.46617
MA0027.12.95767
MA0028.10.658629
MA0029.11.23771
MA0030.11.22561
MA0031.11.15713
MA0038.10.94098
MA0040.11.24388
MA0041.10.847069
MA0042.10.810843
MA0043.11.32783
MA0046.11.31611
MA0048.10.341392
MA0050.10.81185
MA0051.10.936307
MA0052.14.50324
MA0055.10.190716
MA0056.10
MA0057.10.333427
MA0058.10.716037
MA0059.10.714521
MA0060.10.492218
MA0061.16.43078
MA0063.10
MA0066.10.941452
MA0067.11.65513
MA0068.10.405474
MA0069.11.31207
MA0070.11.30033
MA0071.10.897953
MA0072.11.29561
MA0073.10.211629
MA0074.10.935474
MA0076.10.734647
MA0077.11.28751
MA0078.11.04495
MA0081.10.714712
MA0083.11.33535
MA0084.11.84562
MA0087.11.29304
MA0088.11.31954
MA0089.10
MA0090.10.751469
MA0091.10.829044
MA0092.10.785956
MA0093.10.642957
MA0095.10
MA0098.10
MA0100.10.956299
MA0101.13.83913
MA0103.10.628063
MA0105.14.18141
MA0106.10.986396
MA0107.15.90386
MA0108.21.15387
MA0109.10
MA0111.10.767139
MA0113.11.00436
MA0114.11.35563
MA0115.11.57693
MA0116.10.560723
MA0117.11.36676
MA0119.10.695578
MA0122.11.39371
MA0124.11.53432
MA0125.11.44766
MA0130.10
MA0131.11.06461
MA0132.10
MA0133.10
MA0135.11.35921
MA0136.10.948776
MA0139.11.12079
MA0140.10.894983
MA0141.10.712476
MA0142.11.12317
MA0143.11.00455
MA0144.10.531867
MA0145.10.273764
MA0146.10.707589
MA0147.10.565108
MA0148.10.854239
MA0149.10.884158
MA0062.20.449458
MA0035.20.894194
MA0039.20.0526989
MA0138.21.04628
MA0002.20.476938
MA0137.20.666381
MA0104.20.491226
MA0047.20.973066
MA0112.20.264678
MA0065.20.760954
MA0150.10.744617
MA0151.10
MA0152.10.902317
MA0153.11.43021
MA0154.13.19371
MA0155.10.256269
MA0156.10.669101
MA0157.11.09377
MA0158.10
MA0159.10.565904
MA0160.10.871361
MA0161.10
MA0162.10.149099
MA0163.10.122425
MA0164.11.01792
MA0080.20.643061
MA0018.20.987913
MA0099.20.902716
MA0079.20.0373086
MA0102.21.88331
MA0258.10.519674
MA0259.10.575594
MA0442.10



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)

TF#promotersEnrichmentp-valueq-value
EBF1#187938.9064668465690.00141523283560980.00919588764501041
ELF1#199734.258097958807540.01295179875054610.0465299752230155
MAX#414936.452555509007120.003721913834265510.0187575620777327
MEF2A#4205318.74323090964410.0001518243905622470.00195516492304938
MEF2C#4208341.31135449262411.41744912101957e-050.000340863386484372
NFKB1#479035.488063424193840.006049381815655430.0270980650845052
PAX5#507936.669565531177830.003370290999677260.0173770646581405
TCF12#6938310.63446490218640.0008313523990202070.00632424890387292



Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.